More patients opt for mastectomy despite limited, early-stage breast cancer
the ONA take:
According to a new study published in JAMA Surgey, researchers from Vanderbilt University in Nashville, Tennessee, have found that more women with breast cancer are opting for mastectomy, including double mastectomy, rather than undergoing breast conservation surgery despite having early stage disease that is limited to one breast.
For the study, researchers analyzed the records of more than 1.2 million adults women with breast cancer treated from 1998 to 2011 from the National Cancer Data Base. Of those, 35.5% underwent a mastectomy. In the 8 most recent years of the study, the odds of breast conversation surgery-eligible women opting for mastectomy increased 34%.
During the entire period of the study, the rate of double mastectomy in women with cancer in only one breast increased from 1.9% to 11.2%. During the same period, the rate of breast reconstruction in women who underwent mastectomy increased from 11.6% to 36.4%.
The researchers note that the rising rate of mastectomy was most marked among younger women with noninvasive disease, women with smaller tumors, and women with node-negative disease. The findings suggest that factors other than disease burden and cancer control are influencing women to undergo mastectomy.
More women with breast cancer are opting for mastectomy rather than undergoing breast conservation surgery.
The rates of increase were steepest among women with lymph node-negative and in situ (contained) disease. This is a reversal of trends seen since the 1990s when breast conservation surgery (BCS) was found to produce equivalent cancer outcomes and was endorsed as a standard of excellence by a National Institutes of Health Consensus Conference.
Sign Up for Free e-newsletters
- Fluorouracil Associated With Reduced Surgery for Squamous Cell Carcinoma
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Comparison of Survival Outcomes Between Radical Hysterectomy and Definitive Radiochemotherapy in Stage IB1 and IIA1 Cervical Cancer
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Adherence to Skin Cancer Screening Guidelines Beneficial in Management SCC in SOTRs
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|